Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Corrigendum: Transcriptomic profiling of 39 commonly-used neuroblastoma cell lines.

Harenza JL, Diamond MA, Adams RN, Song MM, Davidson HL, Hart LS, Dent MH, Fortina P, Reynolds CP, Maris JM.

Sci Data. 2017 Dec 5;4:170183. doi: 10.1038/sdata.2017.183.

2.

Lacunar-canalicular network in femoral cortical bone is reduced in aged women and is predominantly due to a loss of canalicular porosity.

Ashique AM, Hart LS, Thomas CDL, Clement JG, Pivonka P, Carter Y, Mousseau DD, Cooper DML.

Bone Rep. 2017 Jun 28;7:9-16. doi: 10.1016/j.bonr.2017.06.002. eCollection 2017 Dec.

3.

Electronic bandstructure and van der Waals coupling of ReSe2 revealed by high-resolution angle-resolved photoemission spectroscopy.

Hart LS, Webb JL, Dale S, Bending SJ, Mucha-Kruczynski M, Wolverson D, Chen C, Avila J, Asensio MC.

Sci Rep. 2017 Jul 11;7(1):5145. doi: 10.1038/s41598-017-05361-6.

4.

Transcriptomic profiling of 39 commonly-used neuroblastoma cell lines.

Harenza JL, Diamond MA, Adams RN, Song MM, Davidson HL, Hart LS, Dent MH, Fortina P, Reynolds CP, Maris JM.

Sci Data. 2017 Mar 28;4:170033. doi: 10.1038/sdata.2017.33. Erratum in: Sci Data. 2017 Dec 05;4:170183.

5.

Dual ALK and CDK4/6 Inhibition Demonstrates Synergy against Neuroblastoma.

Wood AC, Krytska K, Ryles HT, Infarinato NR, Sano R, Hansel TD, Hart LS, King FJ, Smith TR, Ainscow E, Grandinetti KB, Tuntland T, Kim S, Caponigro G, He YQ, Krupa S, Li N, Harris JL, Mossé YP.

Clin Cancer Res. 2017 Jun 1;23(11):2856-2868. doi: 10.1158/1078-0432.CCR-16-1114. Epub 2016 Dec 16.

6.

Preclinical Therapeutic Synergy of MEK1/2 and CDK4/6 Inhibition in Neuroblastoma.

Hart LS, Rader J, Raman P, Batra V, Russell MR, Tsang M, Gagliardi M, Chen L, Martinez D, Li Y, Wood A, Kim S, Parasuraman S, Delach S, Cole KA, Krupa S, Boehm M, Peters M, Caponigro G, Maris JM.

Clin Cancer Res. 2017 Apr 1;23(7):1785-1796. doi: 10.1158/1078-0432.CCR-16-1131. Epub 2016 Oct 11.

7.

Lattice Dynamics of the Rhenium and Technetium Dichalcogenides.

Wolverson D, Hart LS.

Nanoscale Res Lett. 2016 Dec;11(1):250. doi: 10.1186/s11671-016-1459-9. Epub 2016 May 13.

8.

Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism.

Oldridge DA, Wood AC, Weichert-Leahey N, Crimmins I, Sussman R, Winter C, McDaniel LD, Diamond M, Hart LS, Zhu S, Durbin AD, Abraham BJ, Anders L, Tian L, Zhang S, Wei JS, Khan J, Bramlett K, Rahman N, Capasso M, Iolascon A, Gerhard DS, Guidry Auvil JM, Young RA, Hakonarson H, Diskin SJ, Look AT, Maris JM.

Nature. 2015 Dec 17;528(7582):418-21. doi: 10.1038/nature15540. Epub 2015 Nov 11.

9.

Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations.

Eleveld TF, Oldridge DA, Bernard V, Koster J, Daage LC, Diskin SJ, Schild L, Bentahar NB, Bellini A, Chicard M, Lapouble E, Combaret V, Legoix-Né P, Michon J, Pugh TJ, Hart LS, Rader J, Attiyeh EF, Wei JS, Zhang S, Naranjo A, Gastier-Foster JM, Hogarty MD, Asgharzadeh S, Smith MA, Guidry Auvil JM, Watkins TB, Zwijnenburg DA, Ebus ME, van Sluis P, Hakkert A, van Wezel E, van der Schoot CE, Westerhout EM, Schulte JH, Tytgat GA, Dolman ME, Janoueix-Lerosey I, Gerhard DS, Caron HN, Delattre O, Khan J, Versteeg R, Schleiermacher G, Molenaar JJ, Maris JM.

Nat Genet. 2015 Aug;47(8):864-71. doi: 10.1038/ng.3333. Epub 2015 Jun 29.

10.

Targeting ER stress-induced autophagy overcomes BRAF inhibitor resistance in melanoma.

Ma XH, Piao SF, Dey S, McAfee Q, Karakousis G, Villanueva J, Hart LS, Levi S, Hu J, Zhang G, Lazova R, Klump V, Pawelek JM, Xu X, Xu W, Schuchter LM, Davies MA, Herlyn M, Winkler J, Koumenis C, Amaravadi RK.

J Clin Invest. 2014 Mar;124(3):1406-17. doi: 10.1172/JCI70454. Epub 2014 Feb 24.

11.

Dual CDK4/CDK6 inhibition induces cell-cycle arrest and senescence in neuroblastoma.

Rader J, Russell MR, Hart LS, Nakazawa MS, Belcastro LT, Martinez D, Li Y, Carpenter EL, Attiyeh EF, Diskin SJ, Kim S, Parasuraman S, Caponigro G, Schnepp RW, Wood AC, Pawel B, Cole KA, Maris JM.

Clin Cancer Res. 2013 Nov 15;19(22):6173-82. doi: 10.1158/1078-0432.CCR-13-1675. Epub 2013 Sep 17.

12.

ER stress-mediated autophagy promotes Myc-dependent transformation and tumor growth.

Hart LS, Cunningham JT, Datta T, Dey S, Tameire F, Lehman SL, Qiu B, Zhang H, Cerniglia G, Bi M, Li Y, Gao Y, Liu H, Li C, Maity A, Thomas-Tikhonenko A, Perl AE, Koong A, Fuchs SY, Diehl JA, Mills IG, Ruggero D, Koumenis C.

J Clin Invest. 2012 Dec;122(12):4621-34. doi: 10.1172/JCI62973. Epub 2012 Nov 12.

13.

High-resolution imaging and antitumor effects of GFP(+) bone marrow-derived cells homing to syngeneic mouse colon tumors.

Finnberg NK, Hart LS, Dolloff NG, Rodgers ZB, Dicker DT, El-Deiry WS.

Am J Pathol. 2011 Nov;179(5):2169-76. doi: 10.1016/j.ajpath.2011.07.028. Epub 2011 Oct 3.

14.

Human colon cancer stem cells are enriched by insulin-like growth factor-1 and are sensitive to figitumumab.

Hart LS, Dolloff NG, Dicker DT, Koumenis C, Christensen JG, Grimberg A, El-Deiry WS.

Cell Cycle. 2011 Jul 15;10(14):2331-8. Epub 2011 Jul 15.

15.

Off-target lapatinib activity sensitizes colon cancer cells through TRAIL death receptor up-regulation.

Dolloff NG, Mayes PA, Hart LS, Dicker DT, Humphreys R, El-Deiry WS.

Sci Transl Med. 2011 Jun 8;3(86):86ra50. doi: 10.1126/scitranslmed.3001384.

16.

Overcoming hypoxia-induced apoptotic resistance through combinatorial inhibition of GSK-3β and CDK1.

Mayes PA, Dolloff NG, Daniel CJ, Liu JJ, Hart LS, Kuribayashi K, Allen JE, Jee DI, Dorsey JF, Liu YY, Dicker DT, Brown JM, Furth EE, Klein PS, Sears RC, El-Deiry WS.

Cancer Res. 2011 Aug 1;71(15):5265-75. doi: 10.1158/0008-5472.CAN-11-1383. Epub 2011 Jun 6.

17.

The GCN2-ATF4 pathway is critical for tumour cell survival and proliferation in response to nutrient deprivation.

Ye J, Kumanova M, Hart LS, Sloane K, Zhang H, De Panis DN, Bobrovnikova-Marjon E, Diehl JA, Ron D, Koumenis C.

EMBO J. 2010 Jun 16;29(12):2082-96. doi: 10.1038/emboj.2010.81. Epub 2010 May 14.

18.

The p53 target Plk2 interacts with TSC proteins impacting mTOR signaling, tumor growth and chemosensitivity under hypoxic conditions.

Matthew EM, Hart LS, Astrinidis A, Navaraj A, Dolloff NG, Dicker DT, Henske EP, El-Deiry WS.

Cell Cycle. 2009 Dec 15;8(24):4168-75.

19.

The combination of 5-fluorouracil plus p53 pathway restoration is associated with depletion of p53-deficient or mutant p53-expressing putative colon cancer stem cells.

Huang C, Zhang XM, Tavaluc RT, Hart LS, Dicker DT, Wang W, El-Deiry WS.

Cancer Biol Ther. 2009 Nov;8(22):2186-93. Epub 2009 Nov 27.

20.

Visualization and enrichment of live putative cancer stem cell populations following p53 inactivation or Bax deletion using non-toxic fluorescent dyes.

Allen JE, Hart LS, Dicker DT, Wang W, El-Deiry WS.

Cancer Biol Ther. 2009 Nov;8(22):2194-205. Epub 2009 Nov 27.

21.

Cell death: a new Par-4 the TRAIL.

Hart LS, El-Deiry WS.

Cell. 2009 Jul 23;138(2):220-2. doi: 10.1016/j.cell.2009.07.007.

22.

Invincible, but not invisible: imaging approaches toward in vivo detection of cancer stem cells.

Hart LS, El-Deiry WS.

J Clin Oncol. 2008 Jun 10;26(17):2901-10. doi: 10.1200/JCO.2008.16.9573. Review.

PMID:
18539971
23.

Effects of low confluency, serum starvation and hypoxia on the side population of cancer cell lines.

Tavaluc RT, Hart LS, Dicker DT, El-Deiry WS.

Cell Cycle. 2007 Oct 15;6(20):2554-62. Epub 2007 Aug 21.

PMID:
17912032
24.

Chemotherapy-resistant side-population of colon cancer cells has a higher sensitivity to TRAIL than the non-SP, a higher expression of c-Myc and TRAIL-receptor DR4.

Sussman RT, Ricci MS, Hart LS, Sun SY, El-Deiry WS.

Cancer Biol Ther. 2007 Sep;6(9):1490-5. Epub 2007 Aug 17.

PMID:
17881904
25.

The adenoviral E4orf6 protein induces atypical apoptosis in response to DNA damage.

Hart LS, Ornelles D, Koumenis C.

J Biol Chem. 2007 Mar 2;282(9):6061-7. Epub 2006 Dec 15.

26.

Arachidonic acid-induced gene expression in colon cancer cells.

Monjazeb AM, High KP, Connoy A, Hart LS, Koumenis C, Chilton FH.

Carcinogenesis. 2006 Oct;27(10):1950-60. Epub 2006 May 15.

PMID:
16704987
27.

Integration of overseas-trained doctors into the Australian medical workforce.

Hart LS, Vernon-Roberts J.

Med J Aust. 2005 Jun 6;182(11):599-600; author reply 600. No abstract available.

PMID:
15938697
28.

The adenovirus E4orf6 protein inhibits DNA double strand break repair and radiosensitizes human tumor cells in an E1B-55K-independent manner.

Hart LS, Yannone SM, Naczki C, Orlando JS, Waters SB, Akman SA, Chen DJ, Ornelles D, Koumenis C.

J Biol Chem. 2005 Jan 14;280(2):1474-81. Epub 2004 Oct 26.

29.
30.

Lidocaine for lumbar punctures. A help not a hindrance.

Carraccio C, Feinberg P, Hart LS, Quinn M, King J, Lichenstein R.

Arch Pediatr Adolesc Med. 1996 Oct;150(10):1044-6.

PMID:
8859136
31.

Plasma beta-endorphin responses to one-hour bicycling and running at 60% VO2max.

Langenfeld ME, Hart LS, Kao PC.

Med Sci Sports Exerc. 1987 Apr;19(2):83-6.

PMID:
3574053
32.

The relationship between changes in drinking behavior and psychological need satisfaction.

Hart LS, Stueland D.

J Stud Alcohol. 1982 Mar;43(3):393-6. No abstract available.

PMID:
7121006
33.
34.
35.
36.

Alcoholism--disability versus handicap; an important distinction.

Hart LS, Trotter AB.

J Stud Alcohol. 1977 Jul;38(7):1443-6. No abstract available.

PMID:
142866

Supplemental Content

Support Center